Dr. Nimesh Desai interviewed about the Mesoblast COVID-19 ARDS trail.
The interview was facilitated by CureTalks.com, in association with the University of Pennsylvania.
UPenn is one of the sites for the ARDS trial and Dr. Nimesh Desai is the Principal Investigator.
One of the interviewers is Jack Aiello, a famous patient advocate for Multiple Myeloma.
PS: Any day now folks. Really. Any day.
Dr. Nimesh Desai interviewed about the Mesoblast COVID-19 ARDS...
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
-0.105(8.37%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.22 | $1.23 | $1.14 | $9.583M | 8.106M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 25000 | 2 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |